BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37304413)

  • 1. Survival and comorbidities in lung cancer patients: Evidence from administrative claims data in Germany.
    Hernandez D; Cheng CY; Hernandez-Villafuerte K; Schlander M
    Oncol Res; 2022; 30(4):173-185. PubMed ID: 37304413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between comorbidities, their treatment and survival in patients with interstitial lung diseases - a claims data analysis.
    Schwarzkopf L; Witt S; Waelscher J; Polke M; Kreuter M
    Respir Res; 2018 Apr; 19(1):73. PubMed ID: 29695236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the lung cancer comorbidome: An analysis of German claims data.
    Murawski M; Walter J; Schwarzkopf L
    Lung Cancer; 2019 Jan; 127():122-129. PubMed ID: 30642540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of comorbidities in COPD patients by disease severity in a German population.
    Greulich T; Weist BJD; Koczulla AR; Janciauskiene S; Klemmer A; Lux W; Alter P; Vogelmeier CF
    Respir Med; 2017 Nov; 132():132-138. PubMed ID: 29229085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database.
    Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM
    Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung and kidney: a dangerous liaison? A population-based cohort study in COPD patients in Italy.
    Fedeli U; De Giorgi A; Gennaro N; Ferroni E; Gallerani M; Mikhailidis DP; Manfredini R; Fabbian F
    Int J Chron Obstruct Pulmon Dis; 2017; 12():443-450. PubMed ID: 28184156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editor's Choice - Comorbidity Patterns Among Patients with Peripheral Arterial Occlusive Disease in Germany: A Trend Analysis of Health Insurance Claims Data.
    Kreutzburg T; Peters F; Rieß HC; Hischke S; Marschall U; Kriston L; L'Hoest H; Sedrakyan A; Debus ES; Behrendt CA
    Eur J Vasc Endovasc Surg; 2020 Jan; 59(1):59-66. PubMed ID: 31744786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbidity and Survival in Lung Cancer Patients.
    Islam KM; Jiang X; Anggondowati T; Lin G; Ganti AK
    Cancer Epidemiol Biomarkers Prev; 2015 Jul; 24(7):1079-85. PubMed ID: 26065838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of health insurance data to identify and quantify the prevalence of main comorbidities in lung cancer patients.
    Jegou D; Dubois C; Schillemans V; Stordeur S; De Gendt C; Camberlin C; Verleye L; Vrijens F
    Lung Cancer; 2018 Nov; 125():238-244. PubMed ID: 30429027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of vascular comorbidities on survival of type 2 diabetes patients on renal replacement therapy.
    Kervinen M; Lehto S; Grönhagen-Riska C; Finne P
    Am J Nephrol; 2012; 36(6):509-15. PubMed ID: 23171532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer.
    Birim O; Kappetein AP; Bogers AJ
    Eur J Cardiothorac Surg; 2005 Nov; 28(5):759-62. PubMed ID: 16157485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbidity Patterns in Patients Newly Diagnosed With Colorectal Cancer: Network-Based Study.
    Qiu H; Wang L; Zhou L; Wang X
    JMIR Public Health Surveill; 2023 Sep; 9():e41999. PubMed ID: 37669093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Comorbidities on Survival in Gastric, Colorectal, and Lung Cancer Patients.
    Morishima T; Matsumoto Y; Koeda N; Shimada H; Maruhama T; Matsuki D; Nakata K; Ito Y; Tabuchi T; Miyashiro I
    J Epidemiol; 2019 Mar; 29(3):110-115. PubMed ID: 30012908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidity in patients undergoing surgery for lung cancer. Do we have an adequate tool to assess it?
    Lembicz M; Gabryel P; Brajer-Luftmann B; Dyszkiewicz W; Batura-Gabryel H
    Adv Respir Med; 2017; 85(2):55-63. PubMed ID: 28440530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of medical comorbidities on the presentation and outcomes of stage I-III non-small-cell lung cancer.
    Ahn DH; Mehta N; Yorio JT; Xie Y; Yan J; Gerber DE
    Clin Lung Cancer; 2013 Nov; 14(6):644-50. PubMed ID: 23886797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbidity and stage at diagnosis among lung cancer patients in the US military health system.
    Lin J; McGlynn KA; Nations JA; Shriver CD; Zhu K
    Cancer Causes Control; 2020 Mar; 31(3):255-261. PubMed ID: 31984449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, incidence and concomitant co-morbidities of type 2 diabetes mellitus in South Western Germany--a retrospective cohort and case control study in claims data of a large statutory health insurance.
    Boehme MW; Buechele G; Frankenhauser-Mannuss J; Mueller J; Lump D; Boehm BO; Rothenbacher D
    BMC Public Health; 2015 Sep; 15():855. PubMed ID: 26334523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of multiple comorbidities on mortality in chronic obstructive pulmonary disease among Korean population: a nationwide cohort study.
    Kim Y; Kim YJ; Cho WK
    BMC Pulm Med; 2021 Feb; 21(1):56. PubMed ID: 33573635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasis comorbidities in Germany: A population-based study on spatiotemporal variations.
    Augustin J; Wolf S; Stephan B; Augustin M; Andrees V
    PLoS One; 2022; 17(3):e0265741. PubMed ID: 35316303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Severity assessment strategies based on administrative data using stroke as an example].
    Schubert I; Hammer A; Köster I
    Z Evid Fortbild Qual Gesundhwes; 2017 Oct; 126():66-75. PubMed ID: 28807634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.